Medicare Enrolled
Dr. Mike Liu, DO
Neurology · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Liu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Liu
Dr. Mike Liu is a neurology specialist in Fort Worth, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Liu performed 1,443 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Liu received a total of $14,239 from 60 pharmaceutical and/or device companies across 725 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Liu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 23% volume in TX
$14,239 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,443
Medicare services
Top 23% in TX for neurology
Not available
Unique patients (not deduplicated)
$136
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
414 | $92 | $232 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
159 | $100 | $432 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
144 | $128 | $311 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
137 | $212 | $764 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
132 | $346 | $734 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
99 | $75 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $123 | $358 |
| New patient office visit, complex (60-74 min) | 85 | $158 | $446 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
64 | $68 | $193 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
64 | $97 | $279 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
23 | $131 | $460 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
19 | $167 | $556 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $69 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,239
Total received (2018-2024)
Avg $2,034/year across 7 years
Top 22% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
725
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,561
2023
$3,868
2022
$3,709
2021
$1,622
2020
$21
2019
$434
2018
$23
Payments by company (2024)
LivaNova USA, Inc.
$954
ABBVIE INC.
$493
PFIZER INC.
$381
SK Life Science, Inc.
$369
Biogen, Inc.
$262
Lilly USA, LLC
$251
Eisai Inc.
$230
Novartis Pharmaceuticals Corporation
$203
Teva Pharmaceuticals USA, Inc.
$190
Sumitomo Pharma America, Inc.
$182
UCB, Inc.
$170
ARGENX US, INC.
$151
Aucta Pharmaceuticals, Inc.
$141
Kyowa Kirin, Inc.
$75
GENZYME CORPORATION
$73
Alexion Pharmaceuticals, Inc.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$50
Genentech USA, Inc.
$48
Abbott Laboratories
$47
Neurelis, Inc.
$42
Alnylam Pharmaceuticals Inc.
$36
Amgen Inc.
$32
Nevro Corp.
$32
GE HEALTHCARE
$23
Lundbeck LLC
$22
Azurity Pharmaceuticals, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$17
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$1,487
ABBVIE INC.
$1,228
LivaNova USA, Inc.
$954
UCB, Inc.
$907
Biogen, Inc.
$871
Novartis Pharmaceuticals Corporation
$721
PFIZER INC.
$614
Sumitomo Pharma America, Inc.
$595
Lilly USA, LLC
$569
Amgen Inc.
$542
ARGENX US, INC.
$462
GENZYME CORPORATION
$389
Alexion Pharmaceuticals, Inc.
$336
Eisai Inc.
$327
Teva Pharmaceuticals USA, Inc.
$300
Kyowa Kirin, Inc.
$260
Biohaven Pharmaceuticals, Inc.
$245
Sunovion Pharmaceuticals Inc.
$211
UPSHER-SMITH LABORATORIES LLC
$204
Avanir Pharmaceuticals, Inc.
$182
Abbott Laboratories
$177
Horizon Therapeutics plc
$174
Neurocrine Biosciences, Inc.
$168
Otsuka America Pharmaceutical, Inc.
$152
EISAI INC.
$148
Biohaven Pharmaceutical Holding Company Ltd.
$148
Amneal Pharmaceuticals LLC
$147
Aucta Pharmaceuticals, Inc.
$141
AbbVie Inc.
$140
Lundbeck LLC
$110
Nevro Corp.
$105
Scilex Pharmaceuticals Inc.
$94
Corium, LLC
$94
Alnylam Pharmaceuticals Inc.
$92
Supernus Pharmaceuticals, Inc.
$72
Janssen Pharmaceuticals, Inc
$71
ACADIA Pharmaceuticals Inc
$71
Neurelis, Inc.
$67
BANNER LIFE SCIENCES, LLC
$57
Acorda Therapeutics, Inc
$55
AQUESTIVE THERAPEUTICS, INC.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$50
Genentech USA, Inc.
$48
GE HealthCare
$41
Currax Pharmaceuticals LLC
$41
Avion Pharmaceuticals
$37
Azurity Pharmaceuticals, Inc.
$36
Averitas Pharma Inc.
$30
Zogenix Inc.
$28
GE HEALTHCARE
$23
AstraZeneca Pharmaceuticals LP
$21
Boston Scientific Corporation
$20
EMD Serono, Inc.
$20
MDD US Operations, LLC
$18
JAZZ PHARMACEUTICALS INC.
$17
Banner Life Sciences, LLC
$17
IMPEL PHARMACEUTICALS INC.
$15
NS Pharma, Inc.
$14
Cala Health, Inc.
$13
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · Briviact · CALA TRIO · CONTRAVE · CREXONT · Dhivy · EMGALITY · FARXIGA · Fintepla · Fycompa · GOCOVRI · HYQVIA · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · Leqembi · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ocrevus Zunovo · Omnia · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · RYTARY · SKYCLARYS · SOLIRIS · SUNOSI · SYMPAZAN · Senza · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VILTEPSO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · ZEMBRACE SYMTOUCH · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
80
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Liu is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Liu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Liu performed 414 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Liu receive payments from pharmaceutical companies?
Yes. Dr. Liu received a total of $14,239 from 60 companies across 725 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liu's costs compare to other neurologists in Fort Worth?
Dr. Liu's average Medicare payment per service is $136. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fort Worth
Browse neurologists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology